Acetyl-(Cys3,Nle4,Arg5,D-2-Nal7,Cys11)-α-MSH (3-11) amide is a constrained α-MSH fragment containing multiple substitutions that fine-tune aromatic interactions and backbone rigidity. The cysteine residues enable potential disulfide stabilization, while D-2-Nal introduces hydrophobic depth. Its acetylated N-terminus supports enhanced conformational control. Researchers employ it to probe melanocortin receptor selectivity.
CAT No: M2723
CAS No:212370-59-7
Synonyms/Alias:212370-59-7;HS024;Long Name (Added to Synonym);DTXSID301034918;AKOS024456803;(4R,10S,13S,16R,19S,22S,25S,28R)-25-butyl-13,22-bis(3-carbamimidamidopropyl)-28-acetamido-19-(1H-imidazol-4-ylmethyl)-10-(1H-indol-3-ylmethyl)-16-(naphthalen-2-ylmethyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octaazacyclononacosane-4-carboxamide;(4R,10S,13S,16R,19S,22S,25S,28R)-28-Acetamido-25-butyl-13,22-bis[3-(diaminomethylideneamino)propyl]-19-(1H-imidazol-5-ylmethyl)-10-(1H-indol-3-ylmethyl)-16-(naphthalen-2-ylmethyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carboxamide;N-Acetyl-L-cysteinyl-L-norleucyl-L-arginyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophylglycyl-L-cysteinamide cyclic (1->9)disulfide;
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.